Reported Earnings • May 24
First quarter 2026 earnings released: EPS: US$0.004 (vs US$0.003 in 1Q 2025) First quarter 2026 results: EPS: US$0.004 (up from US$0.003 in 1Q 2025). Revenue: US$23.9m (up 29% from 1Q 2025). Net income: US$1.16m (up 26% from 1Q 2025). Profit margin: 4.9% (down from 5.0% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Upcoming Dividend • May 04
Upcoming dividend of US$0.028 per share Eligible shareholders must have bought the stock before 11 May 2026. Payment date: 15 May 2026. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.3%. Within top quartile of Chilean dividend payers (6.5%). Higher than average of industry peers (3.8%). Declared Dividend • Apr 02
Dividend of US$0.028 announced Shareholders will receive a dividend of US$0.028. Ex-date: 11th May 2026 Payment date: 15th May 2026 Dividend yield will be 0.007%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is not covered by earnings (107% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.0% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 19% to bring the payout ratio under control. However, EPS has remained steady over the last 5 years so the company would need to improve on their historical growth rates. Reported Earnings • Mar 06
Full year 2025 earnings released: EPS: US$0.028 (vs US$0.032 in FY 2024) Full year 2025 results: EPS: US$0.028 (down from US$0.032 in FY 2024). Revenue: US$141.0m (up 3.6% from FY 2024). Net income: US$7.68m (down 13% from FY 2024). Profit margin: 5.4% (down from 6.5% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. Reported Earnings • Nov 18
Third quarter 2025 earnings released: EPS: US$0.011 (vs US$0.014 in 3Q 2024) Third quarter 2025 results: EPS: US$0.011 (down from US$0.014 in 3Q 2024). Revenue: US$56.6m (up 5.5% from 3Q 2024). Net income: US$2.99m (down 21% from 3Q 2024). Profit margin: 5.3% (down from 7.1% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. New Risk • Sep 20
New major risk - Revenue and earnings growth Earnings have declined by 2.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 110% Cash payout ratio: 191% Earnings have declined by 2.8% per year over the past 5 years. Reported Earnings • May 29
First quarter 2025 earnings released: EPS: US$0.003 (vs US$0.002 in 1Q 2024) First quarter 2025 results: EPS: US$0.003 (up from US$0.002 in 1Q 2024). Revenue: US$18.5m (up 5.4% from 1Q 2024). Net income: US$922.0k (up 65% from 1Q 2024). Profit margin: 5.0% (up from 3.2% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 17% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • May 27
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CL$426, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 10x in the Chemicals industry in South America. Total returns to shareholders of 125% over the past three years. New Risk • May 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chilean stocks, typically moving 3.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 110% Cash payout ratio: 92% Minor Risk Share price has been volatile over the past 3 months (3.7% average weekly change). Upcoming Dividend • Apr 28
Upcoming dividend of US$0.032 per share Eligible shareholders must have bought the stock before 05 May 2025. Payment date: 09 May 2025. The company is paying out more than 100% of its profits and is paying out 92% of its cash flow. Trailing yield: 9.1%. Within top quartile of Chilean dividend payers (7.9%). Higher than average of industry peers (7.2%). Buy Or Sell Opportunity • Apr 18
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 18% to CL$350. The fair value is estimated to be CL$287, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 8.9% over the last 3 years. Earnings per share has declined by 25%. Reported Earnings • Nov 19
Third quarter 2024 earnings released: EPS: US$0.014 (vs US$0.016 in 3Q 2023) Third quarter 2024 results: EPS: US$0.014 (down from US$0.016 in 3Q 2023). Revenue: US$53.6m (up 4.0% from 3Q 2023). Net income: US$3.79m (down 11% from 3Q 2023). Profit margin: 7.1% (down from 8.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Reported Earnings • Aug 17
Second quarter 2024 earnings released: EPS: US$0.002 (vs US$0.001 loss in 2Q 2023) Second quarter 2024 results: EPS: US$0.002 (up from US$0.001 loss in 2Q 2023). Revenue: US$19.1m (down 25% from 2Q 2023). Net income: US$628.0k (up US$1.01m from 2Q 2023). Profit margin: 3.3% (up from net loss in 2Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings. New Risk • May 31
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chilean stocks, typically moving 4.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (100% payout ratio). Share price has been volatile over the past 3 months (4.0% average weekly change). Market cap is less than US$100m (CL$79.8b market cap, or US$86.8m). Reported Earnings • May 19
First quarter 2024 earnings released: EPS: US$0.002 (vs US$0.007 in 1Q 2023) First quarter 2024 results: EPS: US$0.002 (down from US$0.007 in 1Q 2023). Net income: US$559.0k (down 72% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Upcoming Dividend • Apr 29
Upcoming dividend of US$0.036 per share Eligible shareholders must have bought the stock before 06 May 2024. Payment date: 10 May 2024. The company is paying out more than 100% of its profits and is paying out 89% of its cash flow. Trailing yield: 14%. Within top quartile of Chilean dividend payers (12%). Higher than average of industry peers (11%). Reported Earnings • Mar 01
Full year 2023 earnings released: EPS: US$0.036 (vs US$0.052 in FY 2022) Full year 2023 results: EPS: US$0.036 (down from US$0.052 in FY 2022). Revenue: US$137.0m (down 14% from FY 2022). Net income: US$9.75m (down 31% from FY 2022). Profit margin: 7.1% (down from 8.8% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Reported Earnings • Nov 21
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: US$51.5m (down 12% from 3Q 2022). Net income: US$4.25m (down 8.6% from 3Q 2022). Profit margin: 8.2% (up from 7.9% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. New Risk • Aug 14
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.7% Last year net profit margin: 9.7% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 115% Cash payout ratio: 230% Minor Risks Profit margins are more than 30% lower than last year (5.7% net profit margin). Market cap is less than US$100m (CL$67.4b market cap, or US$78.4m). Reported Earnings • Aug 13
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: US$25.6m (down 20% from 2Q 2022). Net loss: US$377.0k (down 111% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 20
First quarter 2023 earnings released: EPS: US$0.007 (vs US$0.014 in 1Q 2022) First quarter 2023 results: EPS: US$0.007 (down from US$0.014 in 1Q 2022). Revenue: US$20.0m (down 31% from 1Q 2022). Net income: US$2.01m (down 48% from 1Q 2022). Profit margin: 10% (down from 13% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 10
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CL$282, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 7x in the Chemicals industry in South America. Total returns to shareholders of 246% over the past three years. Buying Opportunity • May 09
Now 23% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be CL$384, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 38%. Upcoming Dividend • May 01
Upcoming dividend of US$0.052 per share at 11% yield Eligible shareholders must have bought the stock before 08 May 2023. Payment date: 11 May 2023. Payout ratio is on the higher end at 94% but the company is not cash flow positive. Trailing yield: 11%. Lower than top quartile of Chilean dividend payers (14%). Lower than average of industry peers (23%). Reported Earnings • Mar 03
Full year 2022 earnings released: EPS: US$0.052 (vs US$0.055 in FY 2021) Full year 2022 results: EPS: US$0.052 (down from US$0.055 in FY 2021). Revenue: US$160.2m (flat on FY 2021). Net income: US$14.1m (down 6.2% from FY 2021). Profit margin: 8.8% (in line with FY 2021). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jan 03
Investor sentiment improved over the past week After last week's 17% share price gain to CL$349, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 6x in the Chemicals industry in South America. Total returns to shareholders of 369% over the past three years. Reported Earnings • Nov 17
Third quarter 2022 earnings released: EPS: US$0.017 (vs US$0.019 in 3Q 2021) Third quarter 2022 results: EPS: US$0.017 (down from US$0.019 in 3Q 2021). Revenue: US$58.6m (down 5.6% from 3Q 2021). Net income: US$4.64m (down 9.6% from 3Q 2021). Profit margin: 7.9% (down from 8.3% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 1 highly experienced director. 1 independent director (6 non-independent directors). President of the Board Luis Eugenio Ponce Lerou was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Aug 18
Second quarter 2022 earnings released: EPS: US$0.013 (vs US$0.009 in 2Q 2021) Second quarter 2022 results: EPS: US$0.013 (up from US$0.009 in 2Q 2021). Revenue: US$31.9m (up 23% from 2Q 2021). Net income: US$3.60m (up 40% from 2Q 2021). Profit margin: 11% (up from 9.9% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 19
First quarter 2022 earnings released: EPS: US$0.014 (vs US$0.014 in 1Q 2021) First quarter 2022 results: EPS: US$0.014 (vs US$0.014 in 1Q 2021). Revenue: US$29.2m (up 6.1% from 1Q 2021). Net income: US$3.86m (up 3.8% from 1Q 2021). Profit margin: 13% (in line with 1Q 2021). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 03
Investor sentiment deteriorated over the past week After last week's 19% share price decline to CL$218, the stock trades at a trailing P/E ratio of 4.6x. Average trailing P/E is 6x in the Chemicals industry in South America. Total returns to shareholders of 244% over the past three years. Board Change • Apr 26
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 1 highly experienced director. 1 independent director (6 non-independent directors). President of the Board Luis Eugenio Ponce Lerou was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Mar 24
Investor sentiment improved over the past week After last week's 16% share price gain to CL$257, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 7x in the Chemicals industry in South America. Total returns to shareholders of 240% over the past three years. Reported Earnings • Mar 02
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: US$0.055 (up from US$0.028 in FY 2020). Revenue: US$159.3m (up 35% from FY 2020). Net income: US$15.1m (up 99% from FY 2020). Profit margin: 9.5% (up from 6.4% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Dec 08
Upcoming dividend of US$0.037 per share Eligible shareholders must have bought the stock before 15 December 2021. Payment date: 20 December 2021. Payout ratio is on the higher end at 90%, however this is supported by cash flows. Trailing yield: 28%. Within top quartile of Chilean dividend payers (9.3%). Higher than average of industry peers (5.3%). Reported Earnings • Aug 22
Second quarter 2021 earnings released: EPS US$0.009 (vs US$0.002 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$25.9m (up 42% from 2Q 2020). Net income: US$2.57m (up 347% from 2Q 2020). Profit margin: 9.9% (up from 3.2% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 25
First quarter 2021 earnings released: EPS US$0.014 (vs US$0.003 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$27.5m (up 58% from 1Q 2020). Net income: US$3.72m (up 416% from 1Q 2020). Profit margin: 14% (up from 4.2% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 18
Investor sentiment deteriorated over the past week After last week's 16% share price decline to US$231, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 15x in the Chemicals industry in South America. Total returns to shareholders of 109% over the past three years. Upcoming Dividend • May 07
Upcoming dividend of CL$32.18 per share Eligible shareholders must have bought the stock before 14 May 2021. Payment date: 19 May 2021. Trailing yield: 9.2%. Within top quartile of Chilean dividend payers (6.1%). Higher than average of industry peers (3.8%). Reported Earnings • Mar 07
Full year 2020 earnings released: EPS US$0.028 (vs US$0.019 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: US$118.4m (down 7.9% from FY 2019). Net income: US$7.56m (up 49% from FY 2019). Profit margin: 6.4% (up from 4.0% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Mar 05
New 90-day high: CL$243 The company is up 1.0% from its price of CL$242 on 04 December 2020. The Chilean market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. Upcoming Dividend • Dec 10
Upcoming Dividend of US$0.037 Per Share Will be paid on the 21st of December to those who are registered shareholders by the 16th of December. The trailing yield of 5.7% is below the top quartile of Chilean dividend payers (5.9%), but it is higher than industry peers (3.7%). Reported Earnings • Nov 19
Third quarter 2020 earnings released: EPS US$0.014 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$44.9m (up 2.5% from 3Q 2019). Net income: US$3.78m (up 95% from 3Q 2019). Profit margin: 8.4% (up from 4.4% in 3Q 2019). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Nov 14
New 90-day high: CL$201 The company is up 6.0% from its price of CL$189 on 14 August 2020. The Chilean market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period.